☆ 4.5 Letter

Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy

JOURNAL OF DERMATOLOGY (2022)

Effectiveness of COVID-19 vaccines and their challenges (Review)

Gabriella Marfe et al.

Summary: This article discusses the new disease SARS-CoV-2 discovered in Wuhan, China at the end of 2019, and the effectiveness and challenges of the four vaccines currently in use worldwide. It also examines the viral elements used in the coronavirus-19 vaccine that can induce a strong immune response and the potential adverse effects they may cause to individuals.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

添加到收藏夹

Letter Gastroenterology & Hepatology

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer

Fernando Bril

JOURNAL OF HEPATOLOGY (2021)

添加到收藏夹

Letter Endocrinology & Metabolism

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level

Masaaki Miyauchi et al.

JOURNAL OF DIABETES INVESTIGATION (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database

Shiori Hasegawa et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

添加到收藏夹

Review Medicine, General & Internal

Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature

Hafez Mohammad Ammar Abdullah et al.

BMJ CASE REPORTS (2019)

添加到收藏夹

Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy

相关参考文献

Effectiveness of COVID-19 vaccines and their challenges (Review)

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level

Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database

Rapid onset type-1 diabetes and diabetic ketoacidosis secondary to nivolumab immunotherapy: a review of existing literature

导出引文

分享论文